The Latest Time Point of Retreatment (LTPR) as a Novel Method to Determine Antibacterial Effects for Binary Use of Cold Atmospheric Plasma and Conventional Agents

Frontiers in Microbiology
Sandra SchrammTim Maisch

Abstract

Multi-resistant microorganisms are a long-standing problem for public healthcare, as inactivating those resistant pathogens with conventional antibiotics or antiseptics often no longer achieves the expected clinical success. The aim of this in vitro study was to investigate the antibacterial efficacy of binary combinations of conventional antibacterial agents with cold atmospheric plasma (CAP), when both are applied in non-lethal concentrations. In this study, Enterococcus faecalis biofilms were treated with CAP in binary combinations with benzalkonium chloride (BAC), chlorhexidine (CHX), or ciprofloxacin (CIP), respectively, which were applied in different sequences. In order to evaluate effects of binary use of two different antibacterial approaches, the so-called latest time point of retreatment (LTPR) was defined. For this purpose, regrowth curves of the bacteria were measured following the respective treatment combinations. LTPR is defined as the time component of the inflection point of a normalized regrowth curve and allows the rating and interpretation of single or binary treatments with different agents or approaches. Furthermore, LTPR designates the latest time point where a retreatment appears to be appropriate for p...Continue Reading

References

Jun 11, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R C Moellering
Jan 1, 1990·Clinical Microbiology Reviews·B E Murray
Apr 1, 1986·European Journal of Clinical Microbiology·A P Ball
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman
Jan 9, 1999·Clinical Microbiology Reviews·G McDonnell, A D Russell
May 21, 1999·Science·J W CostertonE P Greenberg
Apr 4, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P JoyanesE J Perea
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Apr 5, 2002·Clinical Microbiology Reviews·Rodney M Donlan, J William Costerton
Sep 16, 2005·Journal of Applied Microbiology·P Gilbert, L E Moore
Dec 17, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G M Rossolini, E Mantengoli
Dec 14, 2011·Annual Review of Food Science and Technology·Brendan A Niemira
Apr 3, 2012·Applied and Environmental Microbiology·Tim MaischJulia L Zimmermann
May 15, 2012·Applied and Environmental Microbiology·Tobias G KlämpflHans-Ulrich Schmidt
May 16, 2012·Journal of Industrial Microbiology & Biotechnology·Tim MaischJulia L Zimmermann
Oct 3, 2012·Journal of Internal Medicine·U Römling, C Balsalobre
Mar 20, 2013·BioMed Research International·Aleksandra TaraszkiewiczJoanna Nakonieczna
Jul 18, 2015·Microbiology Spectrum·Philip S Stewart
Jan 1, 2015·The Open Dentistry Journal·Sascha R HerbstSaskia Preissner
Mar 14, 2016·Journal of Photochemistry and Photobiology. B, Biology·Maria Rita RonquiCarla Raquel Fontana
Apr 6, 2017·Scientific Reports·Oleg LunovŠárka Kubinová
Jan 16, 2018·Lasers in Surgery and Medicine·Natanel IluzZvi Malik
Jun 6, 2018·Frontiers in Microbiology·Agata Wozniak, Mariusz Grinholc
Mar 23, 2019·Future Medicinal Chemistry·Joanna NakoniecznaMariusz Grinholc
Apr 11, 2019·Frontiers in Microbiology·Fabian CieplikAli Al-Ahmad

❮ Previous
Next ❯

Software Mentioned

AH
Systat
SPSS
TableCurve

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.